Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: A review

Journal of Pharmaceutical and Biomedical Analysis

Volumn 101, Issue , 2014, Pages 238-250

  Mura, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Analytical characterization in solution; Cyclodextrin; Electroanalytical techniques; Inclusion complex; Polarimetry; Separation techniques; Spectroscopic techniques; Thermoanalytical techniques

Indexed keywords

CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; SOLUTION AND SOLUBILITY;

ANALYTIC METHOD; AQUEOUS SOLUTION; CAPILLARY ELECTROPHORESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CIRCULAR DICHROISM; COMPLEX FORMATION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STABILITY; ELECTRIC CONDUCTIVITY; ELECTRON SPIN RESONANCE; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTHERMAL TITRATION CALORIMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; POLARIMETRY; POLAROGRAPHY; POTENTIOMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; ULTRAVIOLET SPECTROSCOPY; BIOAVAILABILITY; CHEMISTRY; MEDICINAL CHEMISTRY; MICROFLUIDIC ANALYSIS; PROCEDURES; SOLUBILITY; SOLUTION AND SOLUBILITY;

BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DRUG STABILITY; MICROFLUIDIC ANALYTICAL TECHNIQUES; SOLUBILITY; SOLUTIONS;

EID: 84908314961     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.02.022     Document Type: Review

References (116)

1. Tonkova Bacterial cyclodextrin glucanotransferase. Enzyme Microbial Technol. 1998, 22:678-686.
2. Pulley A.O., French D. Studies on the Schardinger dextrins. XI. The isolation of new Schardinger dextrins. Biochem. Biophys. Res. Commun. 1961, 5:11-15.
3. French D., Pulley A.O., Effenberger J.A., Rougvie M.A., Abdullah M. Studies on the Schardinger dextrins. XII. The molecular size and structure of the delta-, epsilon-, zeta-, and eta-dextrins. Arch. Biochem. Biophys. 1965, 111:153-160.
4. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 1998, 98:1743-1753.
5. Fromming K.H., Szejtli J. Cyclodextrins in Pharmacy 1994, Kluwer Academic Publishers, The Netherlands.
6. Szejtli J., Cyclodextrin Technology Kluwer Academic Publishers 1988, Dordrecht, The Netherlands.
7. Duchêne D. New Trends in Cyclodextrins and Derivatives 1991, Editions de Santé, Paris.
8. Albers E., Muller B.W. Cyclodextrin derivatives in pharmaceutics. Crit. Rev. Ther. Drug Carrier Syst. 1995, 12:311-337.
9. Veiga M.D., Merino M., Cirri M., Maestrelli F., Mura P. Comparative study on triclosan interactions in solution and in the solid state with naturally and chemically modified cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 2005, 53:77-83.
10. Maestrelli F., Cecchi M., Cirri M., Capasso G., Mennini N., Mura P. Comparative study of oxaprozin complexation with natural and chemically modified cyclodextrins in solution and in the solid state. J. Incl. Phenom. Macrocycl. Chem. 2009, 63:17-25.
11. Bettinetti G.P., Mura P., Liguori A., Bramanti G., Giordano F. Solubilization and interaction of naproxen with cyclodextrins in aqueous solution and in the solid state. Farmaco 1989, 44:195-213.
12. Bettinetti G.P., Melani F., Mura P., Monnanni M., Giordano F. Carbon-13 NMR study of naproxen interaction with cyclodextrins in solution. J. Pharm. Sci. 1991, 80:1162-1170.
13. Miyake K., Irie T., Arima H., Hirayama F., Uekama K., Hirano M., Okamoto Y. Characterization of itraconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm. 1999, 179:237-245.
14. Calabrò M.L., Tommasini S., Donato P., Stancanelli R., Raneri D., Catania S., Costa C., Villari V., Ficarra P., Ficarra R. The rutin/β-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays. J. Pharm. Biomed. Anal. 2005, 36:1019-1027.
15. Cannavà, Crupi V., Ficarra P., Guardo M., Majolino D., Mazzaglia A., Stancanelli R., Venuti V. Physico-chemical characterization of an amphiphilic cyclodextrin-genistein complex. J. Pharm. Biomed. Anal. 2010, 51:1064-1068.
16. Song W., Yu X., Wang S., Blasier R., Markel D.C., Mao G., Shi T., Ren W. Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application. Int. J. Nanomed. 2011, 6:3173-3186.
17. Chun I.K., Yun D.S. Inclusion complexation of hydrocortisone butyrate with cyclodextrins and dimethyl-β-cyclodextrin in aqueous solution and in solid state. Int. J. Pharm. 1993, 96:91-103.
18. Letellier S., Maupas B., Gramond J.P., Guyon F., Gareil P. Determination of the formation constant for the inclusion complex between rutin and methyl-β-cyclodextrin. Anal. Chim. Acta 1995, 315:357-363.
19. Li N., Zhang Y.H., Xiong X.L., Li Z.G., Jin X.H., Wu Y.N. Study of the physic-chemical properties of trimethoprim with β-cyclodextrin in solution. J. Pharm. Biomed. Anal. 2005, 38:370-374.
20. Jadhav G.S., Vavia P.R. Physicochemical, in silico and in vivo evaluation of a danazol-β-cyclodextrin complex. Int. J. Pharm. 2008, 352:5-16.
21. Ventura C.A., Puglisi G., Giammona G., Bottino F.A. Comparative study on inclusion compounds of 4-biphenylacetic acid with β-cyclodextrin, hydroxy-propylated-β-cyclodextrins, and methylated-β-cyclodextrins. Drug Dev. Ind. Pharm. 1994, 20:2245-2265.
22. Zerrouk N., Ginès Dorado J.M., Arnaud P., Chemtob C. Physical characteristics of inclusion compounds of 5-ASA in αλπηα and β-cyclodextrins. Int. J. Pharm. 1998, 171:19-29.
23. Van Hees T., Piel G., Henry de Hassonville S., Evrard B., Delattre L. Determination of free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. Eur. J. Pharm. Sci. 2002, 15:347-353.
24. Al-Rawashdeh N.A.F. Interactions of nabumetone with β-cyclodextrin studied by fluorescence measurements. J. Incl. Phenom. Macrocycl. Chem. 2005, 51:27-32.
25. Connors K.A. Binding Constants 1987, Wiley, New York.
26. Ziémons E., Dive G., Debrus B., Barillaro V., Frederich M., Lejeune R., Angenot L., Delattre L., Thunus L., Hubert Ph. Study of the physicochemical properties in aqueous medium and molecular modeling of tagitinin C/cyclodextrin complexes. J. Pharm. Biomed. Anal. 2007, 43:910-919.
27. Radi A.E., Eissa S. Voltammetric and spectrophotometric study on the complexation of glibenclamide with β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 2010, 68:417-421.
28. Ungaro F., Giovino C., Catanzano O., Miro A., Mele A., Quaglia F., La Rotonda M.I. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium. Int. J. Pharm. 2011, 404:49-56.
29. Uekama K., Hirayama F., Otagiri M., Otagiri Y., Ikeda K. Inclusion complexation of β-cyclodextrin with some sulfonamides in aqueous solution. Chem. Pharm. Bull. 1978, 26:1162-1167.
30. Mura P., Furlanetto S., Cirri M., Maestrelli F., Corti G., Pinzauti S. Interaction of naproxen with ionic cyclodextrins in aqueous solutions and in the solid state. J. Pharm. Biomed. Anal. 2005, 37:987-994.
31. Stancanelli R., Mazzaglia A., Tommasini S., Calabrò M.L., Villari V., Guardo M., Ficarra P., Ficarra R. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis. J. Pharm. Biomed. Anal. 2007, 44:980-984.
32. Madrid J.M., Villafruela M., Serrano R., Mendicuti F. Experimental thermodynamics and molecular mechanics calculations of inclusion complexes of 9-methyl antracenoate and 1-methyl pyrenoate with beta-cyclodextrin. J. Phys. Chem. B 1999, 103:4847-4853.
33. Lo Meo P., D'Anna F., Riela S., Gruttadauria M., Noto R. Polarimetry as a useful tool for the determination of binding constants between cyclodextrins and organic guest molecules. Tetrahedron Lett. 2006, 47:9099-9102.
34. Junquera E., Aicart E. A fluorimetric, potentiometric and conductimetric study of the aqueous solutions of naproxen and its association with hydroxypropyl-βcyclodextrin. Int. J. Pharm. 1999, 176:169-178.
35. Pinto L.M.A., Fraceto L.F., Santana M.H.A., Pertinhez T.A., Oyama Junior S., de Paula E. Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes. J. Pharm. Biomed. Anal. 2005, 39:956-963.
36. Bettinetti G.P., Mura P., Melani F., Rillosi M., Giordano F. Interactions between naproxen and maltoheptaose, the non-cyclic analog of β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 1996, 25:327-338.
37. Bettinetti G.P., Sorrenti M., Negri A., Setti M., Mura P., Melani F. Interaction of naproxen with Alpha-cyclodextrin and its non cyclic analog maltohexaose. Pharm. Res. 1999, 16:689-694.
38. Dondon R., Fery-Forgues S. Inclusion complex of fluorescent 4-hydroxycoumarin derivatives with native β-cyclodextrin: enhanced stabilization induced by the appended substituent. J. Phys. Chem. B 2001, 105:10715-10722.
39. Fernández L., Martínez-Ohárriz M.C., Martín C., Vèlaz I., Sánchez M., Zornoza A. Analysis of the complexation of gemfibrozil with gamma- and hydroxypropyl-gamma-cyclodextrins. J. Pharm. Biomed. Anal. 2008, 47:943-948.
40. Abdel-Shafi A.A., Al-Shihry S.S. Fluorescence enhancement of 1-napthol-5-sulfonate by forming inclusion complex with beta-cyclodextrin in aqueous solution. Spectrochim. Acta Part A 2008, 72:533-537.
41. Vu A., Schultz J.S., Vullev V.I., Vasquez J.M. Fluorescence enhancement of warfarin induced by interaction with beta-cyclodextrin. Biotechnol. Prog. 2009, 25:906-914.
42. Green T.K., Denoroy L., Parrot S. Fluorescence enhancement of a Meisenheimer complex of adenosine by gamma-cyclodextrin: a thermodynamic and kinetic investigation. J. Org. Chem. 2010, 75:4048-4055.
43. Iglesias-Garcia I., Brandariz I., Iglesias E. Fluorescence study of tetracaine-cyclodextrin inclusion complexes. Supramol. Chem. 2010, 22:228-236.
44. Schneider H.J., Hacket F., Rüdiger V., Ikeda H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 1998, 98:1755-1785.
45. Fielding L. Determination of association constants (Ka) from solution NMR data. Tetrahedron 2000, 56:6151-6170.
46. Greatbanks D., Pickford R. Cyclodextrins as chiral complexing agents in water, and their application to optical purity measurements. Magn. Reson. Chem. 1987, 25:208-215.
47. Rekharsky M., Goldberg R., Schwarz F., Tewari Y., Ross P., Yamashoji Y., Inoue Y. Thermodynamic and nuclear magnetic resonance study of the interactions of αλπηα and βe{open}τα-cyclodextrin with model substances: phenethylamine, ephedrines, and related substances. J. Am. Chem. Soc. 1995, 117:8830-8840.
48. Anczewski W., Dodziuk H., Ejchart A. Manifestation of chiral recognition of camphor enantiomers by α-cyclodextrin in longitudinal and transverse relaxation rates of the corresponding 1:2 complexes and determination of the orientation of the guest inside the host capsule. Chirality 2003, 15:654-659.
49. Mura, Bettinetti G.P., Manderioli A., Faucci M.T., Bramanti G., Sorrenti M. Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state. Int. J. Pharm. 1998, 166:189-203.
50. Garnero C., Longhi M. Study of ascorbic acid interaction with hydroxypropyl-β-cyclodextrin and triethanolamine, separately and in combination. J. Pharm. Biomed. Anal. 2007, 45:536-545.
51. Cameron K.S., Fielding L. NMR diffusion coefficient study of steroid-cyclodextrin inclusion complexes. Magn. Reson. Chem. 2002, 40:106-109.
52. Simova S., Berger S. Diffusion measurements vs. chemical shift titration for determination of association constants on the example of camphor-cyclodextrin complexes. J. Incl. Phenom. Macroc. Chem. 2005, 53:163-170.
53. Bakkour Y., Vermeersch G., Morcellet M., Boschin F., Martel B., Azaroual N. Formation of cyclodextrin inclusion complexes with doxycyclin-hyclate: NMR investigation of their characterisation and stability. J. Incl. Phenom. Macrocycl. Chem. 2006, 54:109-114.
54. Fernandes S.A., Cabeça L.F., Marsaioli A.J., de Paula E. Investigation of tetracaine complexation with beta-cyclodextrins and p-sulphonic acid calixarenes by NOE and PGSE NMR. J. Incl. Phenom. Macrocycl. Chem. 2007, 57:395-401.
55. Jullian C., Miranda S., Zapata-Torres G., Mendizábal F., Olea-Azar C. Studies of inclusion complexes of natural and modified cyclodextrin with (+) catechin by NMR and molecular modeling. Bioorg. Med. Chem. 2007, 15:3217-3224.
56. 1H-NMR and Molecular Modelling techniques for the Investigation of the Inclusion Complex of Econazole with αλπηα-cyclodextrin in the Presence of Malic Acid. J. Pharm. Biomed. Anal. 2000, 23:25-31.
57. Franco C., Schwingel L., Lula I., Koester L.S., Sinisterra R.D., Bassani V.L. Studies on Coumestrol-β-Cyclodextrin: inclusion complex characterization. Int. J. Pharm. 2009, 369:5-11.
58. 1H NMR study. J. Chem. Soc. Perkin Trans. 2002, 2:999-1004.
59. Servais A.C., Rousseau A., Fillet M., Lomsadze K., Salgado A., Crommen J., Chankvetadze B. Capillary electrophoretic and nuclear magnetic resonance studies on the opposite affinity pattern of propranolol enantiomers towards various cyclodextrins. J. Sep. Sci. 2010, 33:1617-1624.
60. Sohajda T., Varga E., Iványi R., Fejõs I., Szente L., Noszál B., Béni S. Separation of vinca alkaloid enantiomers by capillary electrophoresis applying cyclodextrin derivatives and characterization of cyclodextrin complexes by nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 2010, 53:1258-1266.
61. 1H-NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivates. Chem. Phys. Lett. 2010, 500:347-354.
62. Jug M., Mennini N., Kovér K.E., Mura P. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state. J. Pharm. Biomed. Anal. 2014, 91:81-91.
63. Bardelang D., Rockenbauer A., Karoui H., Finet J.P., Tordo P. Inclusion complexes of PBN-type nitrone spin traps and their superoxide spin adducts with cyclodextrin derivatives: parallel determination of the association constants by NMR titrations and 2D-EPR simulations. J. Phys. Chem. B 2005, 10:10521-10530.
64. Pèrez-Cruz F., Aguilera-Venegas B., Lapier M., Sobarzo-Sanchez E., Uriarte Villares E., Olea-Azar C. Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: synthesis, electrochemical, electron spin resonance and molecular modeling studies. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 102:226-234.
65. Ferancová A., Labuda J. Cyclodextrins as electrode modifiers. Fresen. J. Anal. Chem. 2001, 370:1-10.
66. Radi A., Eissa S. Electrochemistry of cyclodextrin inclusion complexes of pharmaceutical compounds. Open Chem. Biomed. Meth. J. 2010, 3:74-85.
67. Matsue T., Osa T., Evans D.H. Determination of some physical constants of cyclodextrin complexes by electrochemical methods. J. Incl. Phenom. Macrocycl. Chem. 1984, 2:547-554.
68. Jones S.P., Parr G.D. Polarographic detection of beta-cyclodextrin inclusion complexes. Int J. Pharm. 1986, 33:105-114.
69. Ibrahim M.S., Shehatta I.S., Al-Nayeli A.A. Voltammetric studies of the interaction of lumazine with cyclodextrins and DNA. J. Pharm. Biomed. Anal. 2002, 28:217-225.
70. Yañez C., Nunez-Vergara L.J., Squella J.A. Differential pulse polarographic and UV-Vis spectrophotometric study of inclusion complexes formed by 1,4-dihydropyridine calcium antagonists, nifedipine and nicardipine with β-cyclodextrin. Electroanalysis 2003, 15:1771-1777.
71. Yañez C., Basquinzay R. Chronocoulometry diffusion coefficients as a measure of cyclodextrin-estradiol complex association. J. Electroanal. Chem. 2008, 622:242-245.
72. Junquera E., Martin-Pastor M., Aicart E. Molecular encapsulation of flurbiprofen and/or ibuprofen by hydroxypropyl-β-cyclodextrin in aqueous solution. Potentiometric and molecular modeling studies. J. Org. Chem. 1998, 63:4349-4358.
73. Kopecky F., Vojtekova M., Kaclik P., Demko M., Bielikova Z. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes. J. Pharm. Pharmacol. 2004, 56:581-587.
74. Béni S., Szakacs Z., Csernak O., Barcza L., Noszal B. Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities. Eur. J. Pharm. Sci. 2007, 167-174.
75. 1H-NMR and molecular modelling. J. Incl. Phenom. Macrocycl. Chem. 2007, 57:519-523.
76. Brandariz I., Iglesias E. Potentiometric characterisation of cyclodextrin inclusion complexes of local anaesthetics. Supramol. Chem. 2011, 23:607-613.
77. Becherirat S., Lanhers M.C., Socha M., Yemloul M., Astier A., Loboda C., Aniceto N., Gibaud S. The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma. Eur. J. Pharm. Biopharm. 2013, 85:560-568.
78. Junquera E., Pena L., Aicart E. Conductimetric Study of the Interaction of beta-cyclodextrin or hydroxypropyl-beta-cyclodextrin with dodecyltrimethylammonium bromide in water solution. Langmuir 1995, 11:4685-4690.
79. Junquera E., Romero J.C., Aicart E. Behavior of tricyclic antidepressants in aqueous solution: self-aggregation and association with β-cyclodextrin. Langmuir 2001, 17:1826-1832.
80. Rafati A.A., Bagheri A., Iloukhani H., Zarinehzad M. Study of inclusion complex formation between a homologous series of n-alkyltrimethyl-ammonium bromides and β-cyclodextrin, using conductometric technique. J. Mol. Liq. 2005, 116:37-41.
81. Iglesias E. Inclusion complexation of novocaine by beta-cyclodextrin in aqueous solutions. J. Org. Chem. 2006, 71:4383-4392.
82. Ali M.S., Rub M.A., Khan F., Al-Lohedan H.A., Din K. Interaction of amphiphilic drug amitriptyline hydrochloride with β-cyclodextrin as studied by conductimetry, surface tensiometry and viscometry. J. Mol. Liq. 2012, 167:115-118.
83. Juvancz Z., Szejtli J. The role of cyclodextrins in chiral selective chromatography. Trends Anal. Chem. 2002, 21:379-388.
84. Kwaterczak A., Duszczyk K., Bielejewska A. Comparison of chiral separation of basic drugs in capillary electrophoresis and liquid chromatography using neutral and negatively charged cyclodextrins. Anal. Chim. Acta 2009, 645:98-104.
85. Larsen K.L., Ziemmermann W. Analysis and characterization of cyclodextrins and their inclusion complexes by affinity capillary electrophoresis. J. Chromatogr. A 1999, 836:3-14.
86. Fujimura K., Ueda T., Kitagawa M., Hiroaki T., Ando T. Reversed-phase retention behavior of aromatic compounds involving β-cyclodextrin inclusion complex formation in the mobile phase. Anal. Chem. 1986, 58:2668-2674.
87. Armstrong D.W., Nome F., Spino L.A., Golden T.D., Efficient Detection Evaluation of cyclodextrin multiple complex formation. J. Am. Chem. Soc. 1996, 108:1418-1421.
88. Hummel J.P., Dreyer W.J. Measurement of protein-binding phenomena by gel filtration. Biochim. Biophys. Acta 1962, 63:530-532.
89. Sadlej-Sosnowska N. Molecular complexation: β-cyclodextrin and steroid hormones inclusion complexes studied by high performance liquid chromatography. J. Pharm. Sci. 1995, 3:1-5.
90. Sadlej-Sosnowska N. Inclusion complexes of steroid hormones with cyclodextrins studied by the Hummel-Dreyer method using reversed-phase liquid chromatography. J. Pharm. Biomed. Anal. 1995, 13:701-704.
91. Flood K.G., Reynolds E.R., Snow N.H. Characterization of inclusion complexes of betamethasone-related steroids with cyclodextrins using high-performance liquid chromatography. J. Chromatogr. A 2000, 903:49-65.
92. Flood K.G., Reynolds E.R., Snow N.H. Determination of apparent association constants of steroid-cyclodextrin inclusion complexes using a modification of the Hummel-Dreyer method. J. Chromatogr. A 2001, 913:261-268.
93. Ravelet C., Geze A., Villet A., Grosset C., Ravel A., Wouessidjewe D., Peyrin E. Chromatographic determination of the association constants between nimesulide and native and modified β-cyclodextrins. J. Pharm. Biomed. Anal. 2002, 29:425-430.
94. Morales Moraes C., Abrami P., de Paula E., Braga A.F.A., Fernandes Fraceto L. Study of the interaction between S(-) bupivacaine and 2-hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 2007, 331:99-106.
95. Yañez C., Basualdo J., Jara-Ulloa P., Squella J.A. Inclusion complexes of estrone and estradiol with β-cyclodextrin: voltammetric and HPLC studies. J. Phys. Org. Chem. 2007, 20:499-505.
96. Dodziuk H., Bielejewska A., Schiff W., Ueda H. Complexation of [2.2]para-cyclophane with β- and γ-cyclodextrins studied by HPLC and NMR. Centr. Eur. J. Chem. 2011, 9:1056-1061.
97. Rogan M.M., Altria K.D. Capillary Electrophoresis Guidebook, Methods in Molecular Biology 1996, vol. 52. Humana Press, Totowa, NJ.
98. Steinbock B., Vichaikul P.P., Steinbock O. Nonlinear analysis of dynamic binding in affinity capillary electrophoresis demonstrated for inclusion complexes of β-cyclodextrin. J. Chromatogr. A 2001, 943:139-146.
99. Chankvetadze B. Combined approach using capillary electrophoresis and NMR spectroscopy for an understanding of enantioselective recognition mechanisms by cyclodextrins. Chem. Soc. Rev. 2004, 33:337-347.
100. Pomponio R., Gotti R., Fiori J., Cavrini V., Mura P., Cirri M., Maestrelli F. Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. J. Pharm. Biomed. Anal. 2004, 35:267-275.
101. Cirri M., Maestrelli F., Orlandini S., Furlanetto S., Pinzauti S., Mura P. Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques. J. Pharm. Biomed. Anal. 2005, 37:995-1002.
102. Sinha V.R., Anitha R., Ghosh S., Nanda A., Kumria R.J. Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state. J. Pharm. Sci 2005, 94:676-687.
103. Lo Meo P., D'Anna F., Riela S., Gruttadauria M., Noto R. Host-guest interactions involving cyclodextrins: useful complementary insights achieved by polarimetry. Tetrahedron 2007, 63:9163-9171.
104. Lo Meo P., D'Anna F., Riela S., Gruttadauria M., Noto R. Binding properties of heptakis-(2,6-di-O-methyl)-β-cyclodextrin and mono-(3,6-anhydro)-β-cyclodextrin: a polarimetric study. J. Incl. Phenom. Macrocycl. Chem. 2011, 71:121-127.
105. Falconer R.J., Collins B.M. Survey of the year 2009: applications of isothermal titration calorimetry. J. Mol. Recognit. 2011, 24:1-16.
106. Bouchemal K., Mazzaferro S. How to conduct and interpret ITC experiments accurately for cyclodextrin-guest interactions. Drug Discov. Today 2012, 17:623-629.
107. Chadha R., Kashid N., Kumar A., Jain D.V.S. Calorimetric studies of diclofenac sodium in aqueous solution of cyclodextrin and water-ethanol mixtures. J. Pharm. Pharmacol. 2002, 54:481-486.
108. Ugwu S.O., Alcala M.J., Bhardwaj R., Blanchard J. Characterization of the complexation of diflunisal with hydroxypropyl-βcyclodextrin. J. Pharm. Biomed. Anal. 1999, 19:391-397.
109. Aki H., Niiya T., Iwase Y., Yamamoto M. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation. J. Pharm. Sci. 2001, 90:1186-1197.
110. Sun D.Z., Wang S.B., Song M.Z., Wei X.L., Yin B.L. A microcalorimetric study of host-guest complexes of α-cyclodextrin with alkyl trimethyl ammonium bromides in aqueous solutions. J. Sol. Chem. 2005, 34:701-712.
111. Illapakurthy A.C., Wyandt C.M., Stodghill S.P. Isothermal titration calorimetry method for determination of cyclodextrin complexation thermodynamics between artemisinin and naproxen under varying environmental conditions. Eur. J. Pharm. Biopharm. 2005, 59:325-332.
112. 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin. Int J. Pharm. 2006, 316:7-13.
113. Perez A.I.R., Tenreiro C.R., Lorenzo C.A., Taboada P., Concheiro A., Labandeira J.J.T. Sertaconazole/hydroxypropyl-β-cyclodextrin complexation: isothermal titration calorimetry and solubility approaches. J. Pharm. Sci. 2006, 95:1751-1762.
114. Perry C.S., Charman S.A., Prankerd R.J., Chiu F.C., Scanlon M.J., Chalmers D., Charman W.N. The binding interaction of synthetic ozonide antimalarials with natural and modified beta-cyclodextrins. J. Pharm. Sci. 2006, 95:146-158.
115. Parker K.M., Stalcup A.M. Affinity capillary electrophoresis and isothermal titration calorimetry for the determination of fatty acid binding with beta-cyclodextrin. J. Chromatogr. A 2008, 1204:171-182.
116. Di Cagno M., Stein P.C., Skalko-Basnet N., Brandl M., Bauer-Brandl A. Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies. J. Pharm. Biomed. Anal. 2011, 55:446-451.